Tytuł pozycji:
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
-
Tytuł :
-
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
-
Autorzy :
-
Kevorkian JP; Department of Diabetes and Endocrinology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France. Electronic address: .
Lopes A; Department of Internal Medicine, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France.
Sène D; Department of Internal Medicine, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France; INSERM UMRS 976, Institut de Recherche Saint Louis, Université de Paris, 75010, Paris, France.
Riveline JP; Department of Diabetes and Endocrinology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France; Centre de Recherche des Cordeliers, INSERM UMRS-1138, IMMEDIAB Laboratory, Université de Paris, 75006, Paris, France.
Vandiedonck C; Centre de Recherche des Cordeliers, INSERM, Université de Paris, IMMEDIAB Laboratory, F-75006, Paris, France.
Féron F; Department of Diabetes and Endocrinology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France.
Nassarmadji K; Department of Internal Medicine, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France.
Mouly S; Department of Internal Medicine, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, INSERM UMRS-1144, 75010, Paris, France.
Mauvais-Jarvis F; Section of Endocrinology and Metabolism, Department of Medicine, Tulane University Health Sciences Campus, New Orleans, LA, United States; Medicine/Endocrine Service, Southeast Louisiana Veterans Health Care System, New Orleans, LA, United States.
Gautier JF; Department of Diabetes and Endocrinology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010, Paris, France; Centre de Recherche des Cordeliers, INSERM UMRS-1138, IMMEDIAB Laboratory, Université de Paris, 75006, Paris, France.
Mégarbane B; Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, INSERM UMRS-1144, 75010, Paris, France. Electronic address: .
- Pokaż więcej
-
Źródło :
-
The Journal of infection [J Infect] 2021 Feb 09. Date of Electronic Publication: 2021 Feb 09.
-
Publication Model :
-
Ahead of Print
-
Typ publikacji :
-
Letter
-
Język :
-
English
-
Imprint Name(s) :
-
Publication: Kent, UK : W.B. Saunders
Original Publication: London, New York, Academic Press.
-
Grant Information :
-
I01 BX003725 United States BX BLRD VA; R01 DK074970 United States DK NIDDK NIH HHS; R01 DK107444 United States DK NIDDK NIH HHS
-
Entry Date(s) :
-
Date Created: 20210212 Latest Revision: 20210219
-
Update Code :
-
20210219
-
PubMed Central ID :
-
PMC7871882
-
DOI :
-
10.1016/j.jinf.2021.02.008
-
PMID :
-
33577902
-
-
Opinia redakcyjna
